All Janssen Biotech, Inc. articles
-
NewsNew biologic effective against major infection in early tests
Researchers have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.
